Re: Tamoxifen may be an effective treatment for BRCA1-related breast cancer irrespective of estrogen receptor status.
Cappelletti
Vera
V
Veneroni
Silvia
S
Coradini
Danila
D
Oriana
Saro
S
Tomasic
Gorana
G
Younes
Mamoun
M
Daidone
Maria Grazia
MG
D018931:Antineoplastic Agents, Hormonal / Q000494:pharmacology* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000208:ethnology / Q000235:genetics* / Q000378:metabolism; D020847:Estrogen Receptor Modulators / Q000494:pharmacology; D005260:Female; D019398:Genes, BRCA1; D006801:Humans; D007585:Jews / Q000706:statistics & numerical data; D009154:Mutation; D011960:Receptors, Estrogen / Q000378:metabolism; D013629:Tamoxifen / Q000494:pharmacology* / Q000627:therapeutic use; D016896:Treatment Outcome
D018931:Antineoplastic Agents, Hormonal; D020847:Estrogen Receptor Modulators; D011960:Receptors, Estrogen; D013629:Tamoxifen